Global Diabetic Retinopathy Market Research Report 2021

August 2016 | 101 pages | ID: G105F2E877DEN
QYResearch

Abstracts

This report studies Diabetic Retinopathy in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

• Bayer
• F. Hoffmann-La Roche
• Novartis
• Regeneron Pharmaceuticals
• Alimera Sciences
• Ampio Pharmaceuticals
• Kowa Group
• Ohr Pharmaceutical
• Promedior
• PSivida
• Quark Pharmaceuticals
• ThromboGenics

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Diabetic Retinopathy in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Corticosteroids drugs
• Anti-VEGF drugs
• Others

Split by application, this report focuses on sales, market share and growth rate of Diabetic Retinopathy in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Diabetic Retinopathy Market Research Report 2021

1 DIABETIC RETINOPATHY OVERVIEW

1.1 Product Overview and Scope of Diabetic Retinopathy
1.2 Diabetic Retinopathy Segment by Types
  1.2.1 Global Sales Market Share of Diabetic Retinopathy by Type in 2015
  1.2.2 Corticosteroids drugs
  1.2.3 Anti-VEGF drugs
  1.2.4 Others
1.3 Diabetic Retinopathy Segment by Applications
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Diabetic Retinopathy Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Diabetic Retinopathy (2011-2021)
  1.5.1 Global Diabetic Retinopathy Sales and Revenue (2011-2021)
  1.5.2 Global Diabetic Retinopathy Sales and Growth Rate (2011-2021)
  1.5.3 Global Diabetic Retinopathy Revenue and Growth Rate (2011-2021)

2 GLOBAL DIABETIC RETINOPATHY MARKET COMPETITION BY MANUFACTURERS

2.1 Global Diabetic Retinopathy Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Diabetic Retinopathy Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Diabetic Retinopathy Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL DIABETIC RETINOPATHY ANALYSIS BY REGION

3.1 Global Diabetic Retinopathy Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Diabetic Retinopathy Sales Market Share by Region (2011-2021)
  3.1.2 Global Diabetic Retinopathy Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
  3.2.2 North America Diabetic Retinopathy Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Diabetic Retinopathy Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
  3.4.2 China Diabetic Retinopathy Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Diabetic Retinopathy Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
  3.6.2 India Diabetic Retinopathy Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Diabetic Retinopathy Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL DIABETIC RETINOPATHY ANALYSIS BY TYPE

4.1 Global Diabetic Retinopathy Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Diabetic Retinopathy Sales and Market Share by Type (2011-2021)
  4.1.2 Global Diabetic Retinopathy Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Corticosteroids drugs Sales, Revenue, Price and Growth (2011-2021)
4.3 Anti-VEGF drugs Sales, Revenue, Price and Growth (2011-2021)
4.4 Others Sales, Revenue, Price and Growth (2011-2021)

5 GLOBAL DIABETIC RETINOPATHY MARKET ANALYSIS BY APPLICATION

5.1 Global Diabetic Retinopathy Sales and Market Share by Application (2011-2021)
5.2 Major Regions Diabetic Retinopathy Sales by Application in 2015 and 2016
  5.2.1 North America Diabetic Retinopathy Sales by Application
  5.2.2 Europe Diabetic Retinopathy Sales by Application
  5.2.3 China Diabetic Retinopathy Sales by Application
  5.2.4 Japan Diabetic Retinopathy Sales by Application
  5.2.5 India Diabetic Retinopathy Sales by Application
  5.2.6 Southeast Asia Diabetic Retinopathy Sales by Application

6 GLOBAL DIABETIC RETINOPATHY MANUFACTURERS ANALYSIS

6.1 Bayer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Diabetic Retinopathy Product Overview
    6.1.2.1 Corticosteroids drugs
    6.1.2.2 Anti-VEGF drugs
    6.1.2.3 Others
  6.1.3 Diabetic Retinopathy Sales, Revenue, Price of Bayer (2015 and 2016)
6.2 F. Hoffmann-La Roche
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Diabetic Retinopathy Product Overview
    6.2.2.1 Corticosteroids drugs
    6.2.2.2 Anti-VEGF drugs
    6.2.2.3 Others
  6.2.3 Diabetic Retinopathy Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)
6.3 Novartis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Diabetic Retinopathy Product Overview
    6.3.2.1 Corticosteroids drugs
    6.3.2.2 Anti-VEGF drugs
    6.3.2.3 Others
  6.3.3 Diabetic Retinopathy Sales, Revenue, Price of Novartis (2015 and 2016)
6.4 Regeneron Pharmaceuticals
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Diabetic Retinopathy Product Overview
    6.4.2.1 Corticosteroids drugs
    6.4.2.2 Anti-VEGF drugs
  6.4.3 Diabetic Retinopathy Sales, Revenue, Price of Regeneron Pharmaceuticals (2015 and 2016)
6.5 Alimera Sciences
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Diabetic Retinopathy Product Overview
    6.5.2.1 Corticosteroids drugs
    6.5.2.2 Anti-VEGF drugs
  6.5.3 Diabetic Retinopathy Sales, Revenue, Price of Alimera Sciences (2015 and 2016)
6.6 Ampio Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Diabetic Retinopathy Product Overview
    6.6.2.1 Corticosteroids drugs
    6.6.2.2 Anti-VEGF drugs
  6.6.3 Diabetic Retinopathy Sales, Revenue, Price of Ampio Pharmaceuticals (2015 and 2016)
6.7 Kowa Group
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Diabetic Retinopathy Product Overview
    6.7.2.1 Corticosteroids drugs
    6.7.2.2 Anti-VEGF drugs
  6.7.3 Diabetic Retinopathy Sales, Revenue, Price of Kowa Group (2015 and 2016)
6.8 Ohr Pharmaceutical
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Diabetic Retinopathy Product Overview
    6.8.2.1 Corticosteroids drugs
    6.8.2.2 Anti-VEGF drugs
  6.8.3 Diabetic Retinopathy Sales, Revenue, Price of Ohr Pharmaceutical (2015 and 2016)
6.9 Promedior
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Diabetic Retinopathy Product Overview
    6.9.2.1 Corticosteroids drugs
    6.9.2.2 Anti-VEGF drugs
  6.9.3 Diabetic Retinopathy Sales, Revenue, Price of Promedior (2015 and 2016)
6.10 PSivida
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Diabetic Retinopathy Product Overview
    6.10.2.1 Corticosteroids drugs
    6.10.2.2 Anti-VEGF drugs
  6.10.3 Diabetic Retinopathy Sales, Revenue, Price of PSivida (2015 and 2016)
6.11 Quark Pharmaceuticals
6.12 ThromboGenics

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Diabetic Retinopathy
Figure Global Sales Market Share of Diabetic Retinopathy by Type in 2015
Table Diabetic Retinopathy Product Type of by Manufacturers
Table Diabetic Retinopathy Sales Market Share by Application in 2015 and 2016
Figure North America Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure China Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure Europe Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure Japan Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure India Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Table Global Diabetic Retinopathy Sales and Revenue (2011-2021)
Figure Global Diabetic Retinopathy Sales and Growth Rate (2011-2021)
Figure Global Diabetic Retinopathy Revenue and Growth Rate (2011-2021)
Table Global Diabetic Retinopathy Sales of Key Manufacturers (2015 and 2016)
Table Global Diabetic Retinopathy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Diabetic Retinopathy Sales Share by Manufacturers
Figure 2016 Diabetic Retinopathy Sales Share by Manufacturers
Table Global Diabetic Retinopathy Revenue by Manufacturers (2015 and 2016)
Table Global Diabetic Retinopathy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Diabetic Retinopathy Revenue Share by Manufacturers
Table 2016 Global Diabetic Retinopathy Revenue Share by Manufacturers
Table Manufacturers Diabetic Retinopathy Manufacturing Base Distribution and Product Type
Table Global Diabetic Retinopathy Sales Market by Region (2011-2021)
Figure Global Diabetic Retinopathy Sales Market by Region (2011-2021)
Figure Global Diabetic Retinopathy Sales Market Share by Region (2011-2021)
Table Global Diabetic Retinopathy Revenue Market by Region (2011-2021)
Table Global Diabetic Retinopathy Revenue Market Share by Region (2011-2021)
Table North America Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
Figure North America Diabetic Retinopathy Sales, Revenue and Growth Rate (2011-2021)
Table Europe Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
Figure Europe Diabetic Retinopathy Sales, Revenue and Growth Rate (2011-2021)
Table China Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
Figure China Diabetic Retinopathy Sales, Revenue and Growth Rate (2011-2021)
Table Japan Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
Figure Japan Diabetic Retinopathy Sales, Revenue and Growth Rate (2011-2021)
Table India Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
Figure India Diabetic Retinopathy Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Diabetic Retinopathy Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Diabetic Retinopathy Sales, Revenue and Growth Rate (2011-2021)
Table Global Diabetic Retinopathy Sales by Type (2011-2021)
Table Global Diabetic Retinopathy Sales Share by Type (2011-2021)
Figure Sales Market Share of Diabetic Retinopathy by Type (2011-2021)
Figure Global Diabetic Retinopathy Sales Growth Rate by Type (2011-2021)
Table Global Diabetic Retinopathy Revenue by Type (2011-2021)
Table Global Diabetic Retinopathy Revenue Share by Type (2011-2021)
Figure Global Diabetic Retinopathy Revenue Growth Rate by Type (2011-2021)
Figure Corticosteroids drugs Sales, Revenue and Growth (2011-2021)
Figure Corticosteroids drugs Price Trend (2011-2021)
Figure Anti-VEGF drugs Sales, Revenue and Growth (2011-2021)
Figure Anti-VEGF drugs Price Trend (2011-2021)
Figure Others Sales, Revenue and Growth (2011-2021)
Figure Others Price Trend (2011-2021)
Table Global Diabetic Retinopathy Sales by Application (2011-2021)
Table Global Diabetic Retinopathy Sales Market Share by Application (2011-2021)
Figure Global Diabetic Retinopathy Sales Market Share by Application in 2015
Figure Global Diabetic Retinopathy Sales Market Share by Application in 2021
Table North America Diabetic Retinopathy Sales by Application (2015 and 2016)
Table Europe Diabetic Retinopathy Sales by Application (2015 and 2016)
Table China Diabetic Retinopathy Sales by Application (2015 and 2016)
Table Japan Diabetic Retinopathy Sales by Application (2015 and 2016)
Table India Diabetic Retinopathy Sales by Application (2015 and 2016)
Table Southeast Asia Diabetic Retinopathy Sales by Application (2015 and 2016)
Table Global Diabetic Retinopathy Sales Growth Rate by Application (2011-2021)
Figure Global Diabetic Retinopathy Sales Growth Rate by Application (2011-2021)
Table Bayer Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Bayer (2015 and 2016)
Table F. Hoffmann-La Roche Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)
Table Novartis Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Novartis (2015 and 2016)
Table Regeneron Pharmaceuticals Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Regeneron Pharmaceuticals (2015 and 2016)
Table Alimera Sciences Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Alimera Sciences (2015 and 2016)
Table Ampio Pharmaceuticals Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Ampio Pharmaceuticals (2015 and 2016)
Table Kowa Group Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Kowa Group (2015 and 2016)
Table Ohr Pharmaceutical Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Ohr Pharmaceutical (2015 and 2016)
Table Promedior Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Promedior (2015 and 2016)
Table PSivida Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of PSivida (2015 and 2016)
Table Quark Pharmaceuticals Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of Quark Pharmaceuticals (2015 and 2016)
Table ThromboGenics Basic Information List
Table Diabetic Retinopathy Sales, Revenue, Price of ThromboGenics (2015 and 2016)